Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sith Sathornsumetee

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Therapeutic strategies to target multiple kinases in glioblastomaSith Sathornsumetee
Annals of the New York Academy of Sciences|November 8, 2008
Designer therapies for glioblastoma multiformeSith Sathornsumetee, Jeremy N Rich
Clinical Neurology and Neurosurgery|January 18, 2006
Friday night palsy: an unusual case of brachial plexus neuropathySith Sathornsumetee, Joel C Morgenlander
Drugs of Today (Barcelona, Spain : 1998)|December 1, 2006
Vandetanib, a novel multitargeted kinase inhibitor, in cancer therapySith Sathornsumetee, Jeremy N Rich
Expert Opinion on Investigational Drugs|February 27, 2009
Targeting multiple kinases in glioblastoma multiformeSith Sathornsumetee, David A Reardon
Anti-Cancer Drugs|September 27, 2006
New approaches to primary brain tumor treatmentSith Sathornsumetee, Jeremy N Rich
Current Pharmaceutical Design|January 29, 2008
Antiangiogenic therapy in malignant glioma: promise and challengeSith Sathornsumetee, Jeremy N Rich
Expert Review of Anticancer Therapy|July 13, 2006
New treatment strategies for malignant gliomasSith Sathornsumetee, Jeremy N Rich
World Neurosurgery|March 11, 2016
High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in OligodendrogliomaSith Sathornsumetee, Pornsuk Cheunsuchon, Tumtip Sangruchi
Clinical Neurology and Neurosurgery|February 18, 2018
Brainstem dysfunction heralding disseminated cryptococcosisPrachaya Srivanitchapoom, Yuvadee Pitakpatapee, Panitta Sitthinamsuwan, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Therapeutic strategies to target multiple kinases in glioblastomaSith Sathornsumetee
Annals of the New York Academy of Sciences|November 8, 2008
Designer therapies for glioblastoma multiformeSith Sathornsumetee, Jeremy N Rich
Clinical Neurology and Neurosurgery|January 18, 2006
Friday night palsy: an unusual case of brachial plexus neuropathySith Sathornsumetee, Joel C Morgenlander
Drugs of Today (Barcelona, Spain : 1998)|December 1, 2006
Vandetanib, a novel multitargeted kinase inhibitor, in cancer therapySith Sathornsumetee, Jeremy N Rich
Expert Opinion on Investigational Drugs|February 27, 2009
Targeting multiple kinases in glioblastoma multiformeSith Sathornsumetee, David A Reardon
Anti-Cancer Drugs|September 27, 2006
New approaches to primary brain tumor treatmentSith Sathornsumetee, Jeremy N Rich
Current Pharmaceutical Design|January 29, 2008
Antiangiogenic therapy in malignant glioma: promise and challengeSith Sathornsumetee, Jeremy N Rich
Expert Review of Anticancer Therapy|July 13, 2006
New treatment strategies for malignant gliomasSith Sathornsumetee, Jeremy N Rich
World Neurosurgery|March 11, 2016
High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in OligodendrogliomaSith Sathornsumetee, Pornsuk Cheunsuchon, Tumtip Sangruchi
Clinical Neurology and Neurosurgery|February 18, 2018
Brainstem dysfunction heralding disseminated cryptococcosisPrachaya Srivanitchapoom, Yuvadee Pitakpatapee, Panitta Sitthinamsuwan, et al.
Pageof 6